Elevation Oncology (ELEV) Institutional Ownership → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free ELEV Stock Alerts $3.97 +0.14 (+3.66%) (As of 05/29/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Elevation Oncology (NASDAQ:ELEV)CurrentInstitutional OwnershipPercentage83.70%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$52.49MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$7.53M Get ELEV Insider Trade Alerts Want to know when executives and insiders are buying or selling Elevation Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ELEV Institutional Buying and Selling by Quarter Ad WealthPressNew trading system called MSFT, NVDA & MSFTLook 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! Elevation Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/24/2024 Farallon Capital Management LLC3,886,663$19.94M0.1%N/A7.113% 5/17/2024 Artal Group S.A.1,513,015$7.76M0.2%N/A2.769% 5/17/2024 Ikarian Capital LLC148,089$760K0.1%-87.4%0.271% 5/15/2024 venBio Partners LLC2,696,133$13.83M4.9%-7.5%4.934% 5/15/2024 Darwin Global Management Ltd.2,332,928$11.97M1.6%N/A4.270% 5/15/2024 Affinity Asset Advisors LLC1,268,825$6.51M0.8%N/A2.322% Get the Latest News and Ratings for ELEV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Elevation Oncology and its competitors with MarketBeat's FREE daily newsletter. 5/10/2024 Vanguard Group Inc.1,532,045$7.86M0.0%+30.8%2.804% 5/7/2024 SG Americas Securities LLC12,244$63K0.0%N/A0.022% 11/15/2023 Armistice Capital LLC750,000$497K0.0%-68.7%1.768% 8/15/2023 Sphera Funds Management LTD.900,000$1.37M0.2%N/A2.124% 8/15/2023 Caxton Corp21,725$33K0.1%-68.2%0.051% 8/11/2023 Velan Capital Investment Management LP497,299$756K0.7%N/A1.173% 8/11/2023 ExodusPoint Capital Management LP1,499,319$2.28M0.0%N/A6.160% 5/15/2023 Sio Capital Management LLC876,611$1.67M0.8%+143.7%3.685% 5/1/2023 Virtu Financial LLC27,286$52K0.0%N/A0.115% 2/15/2023 Tang Capital Management LLC479,854$456K0.1%N/A2.059% 2/13/2023 BML Capital Management LLC39,963$38K0.0%N/A0.172% 11/14/2022 Annandale Capital LLC30,000$34K0.0%N/A0.129% 11/14/2022 Cormorant Asset Management LP1,952,032$2.21M0.2%-1.6%8.377% 8/16/2022 venBio Partners LLC1,866,339$2.61M0.7%-28.4%8.013% 8/10/2022 Kennedy Capital Management Inc.149,893$210K0.0%+968.4%0.644% 4/26/2022 Marquette Asset Management LLC38,951$98K0.0%+332.5%0.168% 4/25/2022 Bailard Inc.23,500$59K0.0%N/A0.101% 2/18/2022 TCG Crossover Management LLC555,000$3.34M1.6%N/A2.389% 2/15/2022 Kennedy Capital Management Inc.15,485$93K0.0%N/A0.067% 2/14/2022 Boxer Capital LLC872,780$5.25M0.2%-34.9%3.758% 2/14/2022 Sio Capital Management LLC250,000$1.51M0.5%N/A1.076% 1/19/2022 Marquette Asset Management LLC9,006$54K0.0%N/A0.039% 11/16/2021 Schonfeld Strategic Advisors LLC18,044$141K0.0%-29.8%0.078% 11/16/2021 Janus Henderson Group PLC1,220,205$9.38M0.0%+18.3%5.254% 11/16/2021 Caxton Corp48,183$375K0.3%+21.7%0.207% 11/9/2021 BlackRock Inc.23,837$186K0.0%N/A0.103% 8/17/2021 Weiss Multi Strategy Advisers LLC15,037$204K0.0%N/A0.066% 8/17/2021 Woodline Partners LP112,431$1.53M0.0%N/A0.493% 8/17/2021 Samsara BioCapital LLC932,239$12.65M1.6%N/A4.085% 8/17/2021 Sphera Funds Management LTD.30,000$407K0.0%N/A0.131% 8/17/2021 Millennium Management LLC123,062$1.67M0.0%N/A0.539% 8/17/2021 BVF Inc. IL1,590,291$21.58M0.8%N/A6.968% 8/17/2021 Boxer Capital LLC1,341,530$18.21M0.6%N/A5.878% 8/17/2021 Caas Capital Management LP60,000$814K0.0%N/A0.263% The Tesla Indicator Is Bullish (Ad)If you ever thought you’re too late to see significant returns from Tesla stock… Please read this short email. Because a world class trading expert just showed me an entirely new way to target hefty returns inside shares of Tesla. It’s all thanks to one unique trade setup that’s specific to this legendary stock. It’s called the Perfect Tesla Trade. And it couldn’t be more straightforward…>> Click here to join Lance now and he’ll teach you how to execute the Perfect Tesla Trade inside yo8/17/2021 Caxton Corp39,586$537K0.4%N/A0.173% 8/16/2021 LMR Partners LLP31,300$425K0.0%N/A0.137% 8/16/2021 Point72 Asset Management L.P.50,000$679K0.0%N/A0.219% 8/16/2021 venBio Partners LLC2,608,167$35.39M4.2%N/A11.428% 8/16/2021 Alyeska Investment Group L.P.125,000$1.70M0.0%N/A0.548% 8/16/2021 Schonfeld Strategic Advisors LLC25,700$349K0.0%N/A0.113% 8/16/2021Pinz Capital Management LP36,400$494K0.1%N/A0.159% 8/16/2021 Maven Securities LTD16,000$204K0.0%N/A0.070% 8/16/2021 Goldman Sachs Group Inc.62,500$848K0.0%N/A0.274% 8/13/2021 Northern Trust Corp4,803$65K0.0%N/A0.021% 8/13/2021 Qube Research & Technologies Ltd24,255$329K0.0%N/A0.106% 8/13/2021 Vanguard Group Inc.60,000$814K0.0%N/A0.263% 8/12/2021 Monashee Investment Management LLC140,000$1.90M0.2%N/A0.613% 8/11/2021 Ghost Tree Capital LLC100,000$1.36M0.4%N/A0.438% (Data available from 1/1/2016 forward) ELEV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ELEV shares? During the previous two years, 20 institutional investors and hedge funds held shares of Elevation Oncology. The most heavily invested institutionals were Farallon Capital Management LLC ($19.94M), venBio Partners LLC ($13.83M), Darwin Global Management Ltd. ($11.97M), Vanguard Group Inc. ($7.86M), Artal Group S.A. ($7.76M), Affinity Asset Advisors LLC ($6.51M), and ExodusPoint Capital Management LP ($2.28M).Learn more on ELEV's institutional investors. What percentage of Elevation Oncology stock is owned by institutional investors? 83.70% of Elevation Oncology stock is owned by institutional investors. Learn more on ELEV's institutional investor holdings. Which institutional investors have been buying Elevation Oncology stock? Of the 15 institutional investors that purchased Elevation Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Farallon Capital Management LLC ($3.89M), Darwin Global Management Ltd. ($2.33M), Artal Group S.A. ($1.51M), ExodusPoint Capital Management LP ($1.50M), Affinity Asset Advisors LLC ($1.27M), Sphera Funds Management LTD. ($900K), and Sio Capital Management LLC ($516.88K). How much institutional buying is happening at Elevation Oncology? Institutional investors have bought a total of 13,500,938 shares in the last 24 months. This purchase volume represents approximately $54.25M in transactions. Which Elevation Oncology major shareholders have been selling company stock? The following institutional investors have sold Elevation Oncology stock in the last 24 months: Armistice Capital LLC ($1.65M), Ikarian Capital LLC ($1.02M), venBio Partners LLC ($959.95K), Caxton Corp ($46.60K), and Cormorant Asset Management LP ($31.14K). How much institutional selling is happening at Elevation Oncology? Institutional investors have sold a total of 3,707,535 shares in the last 24 months. This volume of shares sold represents approximately $8.61M in transactions. Related Companies: GNFT Major Shareholders INMB Major Shareholders OPT Major Shareholders FENC Major Shareholders IPSC Major Shareholders GLUE Major Shareholders CMPX Major Shareholders ABOS Major Shareholders AGEN Major Shareholders IPHA Major Shareholders This page (NASDAQ:ELEV) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBiden Nomination CANCELED?The Freeport SocietyThe 7th Trillion Dollar Company?The Oxford ClubThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarGold Set to EXPLODE!Gold Safe Exchange[Urgent!] Generational Wealth GameplanCrypto 101 MediaGet out of dollars—get into America’s new money insteadStansberry ResearchThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevation Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.